Room: N-115/116

309.2 Alemtuzumab and Infliximab join forces: Together we are strong

Petra Reinke, Germany

inst.med.immunology and berlin-brandenburg center for regenerative therapies (bcrt)
charité university medicine berlin



© 2024 TTS2018